Follow us for updates
© 2021 reportr.world
Read the Story →

Duterte on Ivermectin vs. COVID: It's Up to Doctor and Patient

"I leave it to the doctor-patient relationship."
by Clara Rosales
5 hours ago
Photo/s: Presidential Photo
Shares

President Rodrigo Duterte said Saturday that use of ivermectin as COVID-19 treatment is up to the patient and their doctor.

"Ako, really, I leave it to the doctor-patient relationship. If the doctor belives in good faith that it can help and the patient also believes in his heart that he well get well, we leave it up to you to decide," Duterte said in his address taped Friday night.

Ivermectin, an anti-parastic drug for animals, was being used by some Filipinos as treatment for the coronavirus, with some doctors prescribing it as treatment or preventive medicine.

Though studies have been conducted on its efficacy on COVID-19, findings supporting its status as an effective treatment are yet to be published.

"Nobody has published a medical journal which the doctors rely on na nagsasabi na all of these tests were conducted and the result is what is being laid down here," he said.

Continue reading below ↓

Intake of the drug may have several side effects including diarrhea and vomiting.

See Also

"If both doctor and patient believe that it can help that it will produce result, then sa inyo na yan. I leave it up to your discernment, kung tama ba."

Testimonies passed on in group chats and social media have spiked demand for the anti-parasitic.

"For some people, it could be quite a good gamble to embark on," Duterte said. 

Continue reading below ↓
Recommended Videos

Reportr is now on Quento. Download the app or visit the Quento website for more articles and videos from Reportr and your favorite websites.

Latest Headlines
more about:
Read Next
Recent News
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.